BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25978616)

  • 1. Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosis.
    Clements D; Dongre A; Krymskaya VP; Johnson SR
    PLoS One; 2015; 10(5):e0126025. PubMed ID: 25978616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast-Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis.
    Babaei-Jadidi R; Dongre A; Miller S; Castellanos Uribe M; Stewart ID; Thompson ZM; Nateri AS; Bradding P; May ST; Clements D; Johnson SR
    Am J Respir Crit Care Med; 2021 Aug; 204(4):431-444. PubMed ID: 33882264
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response.
    Miller S; Stewart ID; Clements D; Soomro I; Babaei-Jadidi R; Johnson SR
    J Pathol Clin Res; 2020 Jul; 6(3):215-226. PubMed ID: 32352655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin K in Lymphangioleiomyomatosis: LAM Cell-Fibroblast Interactions Enhance Protease Activity by Extracellular Acidification.
    Dongre A; Clements D; Fisher AJ; Johnson SR
    Am J Pathol; 2017 Aug; 187(8):1750-1762. PubMed ID: 28623674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis.
    Ando K; Fujino N; Mitani K; Ota C; Okada Y; Kondo T; Mizobuchi T; Kurihara M; Suzuki K; Hoshika Y; Ebana H; Kobayashi E; Takahashi K; Kubo H; Seyama K
    Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L899-908. PubMed ID: 27016587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
    Kristof AS; You Z; Han YS; Giaid A
    Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.
    Steagall WK; Pacheco-Rodriguez G; Darling TN; Torre O; Harari S; Moss J
    Am J Respir Cell Mol Biol; 2018 Jun; 58(6):678-683. PubMed ID: 29406787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross talk between LAM cells and fibroblasts may influence alveolar epithelial cell behavior in lymphangioleiomyomatosis.
    Clements D; Miller S; Babaei-Jadidi R; Adam M; Potter SS; Johnson SR
    Am J Physiol Lung Cell Mol Physiol; 2022 Feb; 322(2):L283-L293. PubMed ID: 34936509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis.
    Sun Y; Zhang E; Lao T; Pereira AM; Li C; Xiong L; Morrison T; Haley KJ; Zhou X; Yu JJ
    Horm Cancer; 2014 Oct; 5(5):284-98. PubMed ID: 25069840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis.
    Pacheco-Rodriguez G; Steagall WK; Crooks DM; Stevens LA; Hashimoto H; Li S; Wang JA; Darling TN; Moss J
    Cancer Res; 2007 Nov; 67(21):10573-81. PubMed ID: 17975002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma.
    Clements D; Markwick LJ; Puri N; Johnson SR
    J Immunol; 2010 Aug; 185(3):1812-21. PubMed ID: 20585037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis.
    Lesma E; Chiaramonte E; Ancona S; Orpianesi E; Di Giulio AM; Gorio A
    Biomed Res Int; 2015; 2015():315240. PubMed ID: 25699271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation.
    Goncharova EA; Goncharov DA; Chisolm A; Spaits MS; Lim PN; Cesarone G; Khavin I; Tliba O; Amrani Y; Panettieri RA; Krymskaya VP
    Mol Pharmacol; 2008 Mar; 73(3):778-88. PubMed ID: 18094073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.
    Lesma E; Ancona S; Sirchia SM; Orpianesi E; Grande V; Colapietro P; Chiaramonte E; Di Giulio AM; Gorio A
    J Cell Mol Med; 2014 May; 18(5):766-79. PubMed ID: 24606538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
    Merrilees MJ; Hankin EJ; Black JL; Beaumont B
    J Pathol; 2004 Jun; 203(2):653-60. PubMed ID: 15141380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Pluripotent Stem Cell-Derived
    Julian LM; Delaney SP; Wang Y; Goldberg AA; Doré C; Yockell-Lelièvre J; Tam RY; Giannikou K; McMurray F; Shoichet MS; Harper ME; Henske EP; Kwiatkowski DJ; Darling TN; Moss J; Kristof AS; Stanford WL
    Cancer Res; 2017 Oct; 77(20):5491-5502. PubMed ID: 28830860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.
    Valencia JC; Pacheco-Rodriguez G; Carmona AK; Xavier J; Bruneval P; Riemenschneider WK; Ikeda Y; Yu ZX; Ferrans VJ; Moss J
    Am J Respir Cell Mol Biol; 2006 Jul; 35(1):40-7. PubMed ID: 16474096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.
    Valencia JC; Steagall WK; Zhang Y; Fetsch P; Abati A; Tsukada K; Billings E; Hearing VJ; Yu ZX; Pacheco-Rodriguez G; Moss J
    Chest; 2015 Mar; 147(3):771-777. PubMed ID: 25411763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
    Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
    Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.